nodes	percent_of_prediction	percent_of_DWPC	metapath
Folic Acid—MTHFR—prostate cancer	0.188	0.622	CbGaD
Folic Acid—ABCC11—Conjugated Estrogens—prostate cancer	0.153	0.342	CbGbCtD
Folic Acid—CYP2E1—prostate cancer	0.114	0.378	CbGaD
Folic Acid—ABCC3—Conjugated Estrogens—prostate cancer	0.0424	0.0944	CbGbCtD
Folic Acid—ABCC4—Conjugated Estrogens—prostate cancer	0.0324	0.0721	CbGbCtD
Folic Acid—ABCG2—Cabazitaxel—prostate cancer	0.0272	0.0606	CbGbCtD
Folic Acid—ABCG2—Estrone—prostate cancer	0.0266	0.0593	CbGbCtD
Folic Acid—ABCC3—Etoposide—prostate cancer	0.0243	0.0541	CbGbCtD
Folic Acid—CYP2E1—Estrone—prostate cancer	0.019	0.0423	CbGbCtD
Folic Acid—ABCG2—Conjugated Estrogens—prostate cancer	0.0174	0.0388	CbGbCtD
Folic Acid—ABCC3—Doxorubicin—prostate cancer	0.0166	0.0369	CbGbCtD
Folic Acid—ABCG2—Mitoxantrone—prostate cancer	0.0158	0.0352	CbGbCtD
Folic Acid—ABCG2—Estradiol—prostate cancer	0.0153	0.034	CbGbCtD
Folic Acid—SLC22A6—Conjugated Estrogens—prostate cancer	0.0141	0.0314	CbGbCtD
Folic Acid—CYP2E1—Mitoxantrone—prostate cancer	0.0113	0.0251	CbGbCtD
Folic Acid—ABCG2—Etoposide—prostate cancer	0.00998	0.0222	CbGbCtD
Folic Acid—ABCG2—Docetaxel—prostate cancer	0.00913	0.0203	CbGbCtD
Folic Acid—CYP2E1—Etoposide—prostate cancer	0.00711	0.0158	CbGbCtD
Folic Acid—ABCG2—Doxorubicin—prostate cancer	0.0068	0.0152	CbGbCtD
Folic Acid—SLC25A32—prostate gland—prostate cancer	0.00302	0.0506	CbGeAlD
Folic Acid—FOLR2—prostate gland—prostate cancer	0.003	0.0502	CbGeAlD
Folic Acid—FOLR3—bone marrow—prostate cancer	0.00278	0.0465	CbGeAlD
Folic Acid—SLC25A32—seminal vesicle—prostate cancer	0.00256	0.0428	CbGeAlD
Folic Acid—FOLR2—seminal vesicle—prostate cancer	0.00254	0.0425	CbGeAlD
Folic Acid—FOLR3—testis—prostate cancer	0.00238	0.0398	CbGeAlD
Folic Acid—SLC46A1—prostate gland—prostate cancer	0.00235	0.0393	CbGeAlD
Folic Acid—GGH—prostate gland—prostate cancer	0.00231	0.0386	CbGeAlD
Folic Acid—SLC25A32—urethra—prostate cancer	0.00202	0.0339	CbGeAlD
Folic Acid—FOLR2—urethra—prostate cancer	0.00201	0.0336	CbGeAlD
Folic Acid—SLC46A1—seminal vesicle—prostate cancer	0.00199	0.0332	CbGeAlD
Folic Acid—GGH—seminal vesicle—prostate cancer	0.00195	0.0327	CbGeAlD
Folic Acid—GGH—renal system—prostate cancer	0.00157	0.0263	CbGeAlD
Folic Acid—SLC25A32—bone marrow—prostate cancer	0.00156	0.0261	CbGeAlD
Folic Acid—GGH—urethra—prostate cancer	0.00155	0.0259	CbGeAlD
Folic Acid—FOLR2—bone marrow—prostate cancer	0.00155	0.0259	CbGeAlD
Folic Acid—CYP2E1—urine—prostate cancer	0.00154	0.0257	CbGeAlD
Folic Acid—ABCC11—testis—prostate cancer	0.00147	0.0246	CbGeAlD
Folic Acid—MTHFR—prostate gland—prostate cancer	0.00146	0.0244	CbGeAlD
Folic Acid—SLC25A32—testis—prostate cancer	0.00133	0.0223	CbGeAlD
Folic Acid—FOLR2—testis—prostate cancer	0.00132	0.0221	CbGeAlD
Folic Acid—GGH—bone marrow—prostate cancer	0.00119	0.0199	CbGeAlD
Folic Acid—ABCC3—prostate gland—prostate cancer	0.00109	0.0183	CbGeAlD
Folic Acid—SLC46A1—testis—prostate cancer	0.00103	0.0173	CbGeAlD
Folic Acid—GGH—testis—prostate cancer	0.00102	0.017	CbGeAlD
Folic Acid—SLC25A32—lymph node—prostate cancer	0.000966	0.0162	CbGeAlD
Folic Acid—FOLR2—lymph node—prostate cancer	0.000958	0.016	CbGeAlD
Folic Acid—ABCC4—prostate gland—prostate cancer	0.000902	0.0151	CbGeAlD
Folic Acid—Raltitrexed—TYMS—prostate cancer	0.000752	0.204	CrCbGaD
Folic Acid—SLC46A1—lymph node—prostate cancer	0.00075	0.0125	CbGeAlD
Folic Acid—ABCC3—renal system—prostate cancer	0.000745	0.0125	CbGeAlD
Folic Acid—GGH—lymph node—prostate cancer	0.000738	0.0123	CbGeAlD
Folic Acid—MTHFR—testis—prostate cancer	0.000643	0.0108	CbGeAlD
Folic Acid—ABCG2—prostate gland—prostate cancer	0.000637	0.0107	CbGeAlD
Folic Acid—ABCC4—renal system—prostate cancer	0.000615	0.0103	CbGeAlD
Folic Acid—Methotrexate—AOX1—prostate cancer	0.000599	0.163	CrCbGaD
Folic Acid—Leucovorin—TYMS—prostate cancer	0.00057	0.154	CrCbGaD
Folic Acid—Pralatrexate—TYMS—prostate cancer	0.00057	0.154	CrCbGaD
Folic Acid—CYP2E1—prostate gland—prostate cancer	0.000551	0.00922	CbGeAlD
Folic Acid—ABCG2—seminal vesicle—prostate cancer	0.000539	0.00901	CbGeAlD
Folic Acid—ABCC3—testis—prostate cancer	0.000481	0.00805	CbGeAlD
Folic Acid—CYP2E1—seminal vesicle—prostate cancer	0.000466	0.0078	CbGeAlD
Folic Acid—MTHFR—lymph node—prostate cancer	0.000466	0.0078	CbGeAlD
Folic Acid—ABCC4—bone marrow—prostate cancer	0.000465	0.00778	CbGeAlD
Folic Acid—Pemetrexed—TYMS—prostate cancer	0.000455	0.124	CrCbGaD
Folic Acid—ABCG2—urethra—prostate cancer	0.000426	0.00713	CbGeAlD
Folic Acid—Decreased appetite—Flutamide—prostate cancer	0.00041	0.00536	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Nilutamide—prostate cancer	0.000409	0.00534	CcSEcCtD
Folic Acid—Bronchospasm—Conjugated Estrogens—prostate cancer	0.000408	0.00533	CcSEcCtD
Folic Acid—Confusional state—Cabazitaxel—prostate cancer	0.000402	0.00525	CcSEcCtD
Folic Acid—ABCC4—testis—prostate cancer	0.000397	0.00665	CbGeAlD
Folic Acid—Dyspepsia—Estradiol valerate/Dienogest—prostate cancer	0.000392	0.00512	CcSEcCtD
Folic Acid—Feeling abnormal—Nilutamide—prostate cancer	0.000391	0.0051	CcSEcCtD
Folic Acid—Feeling abnormal—Flutamide—prostate cancer	0.000389	0.00508	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Estradiol valerate/Dienogest—prostate cancer	0.000385	0.00502	CcSEcCtD
Folic Acid—Anorexia—Cabazitaxel—prostate cancer	0.00038	0.00497	CcSEcCtD
Folic Acid—Pruritus—Estramustine—prostate cancer	0.000378	0.00494	CcSEcCtD
Folic Acid—Dyspnoea—Degarelix—prostate cancer	0.000378	0.00493	CcSEcCtD
Folic Acid—CYP2E1—renal system—prostate cancer	0.000376	0.00629	CbGeAlD
Folic Acid—Depression—Goserelin—prostate cancer	0.000372	0.00486	CcSEcCtD
Folic Acid—CYP2E1—urethra—prostate cancer	0.000369	0.00617	CbGeAlD
Folic Acid—Depression—Conjugated Estrogens—prostate cancer	0.000369	0.00481	CcSEcCtD
Folic Acid—Decreased appetite—Degarelix—prostate cancer	0.000368	0.00481	CcSEcCtD
Folic Acid—Irritability—Estradiol—prostate cancer	0.000367	0.00479	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Degarelix—prostate cancer	0.000366	0.00477	CcSEcCtD
Folic Acid—Pruritus—Estrone—prostate cancer	0.000361	0.00471	CcSEcCtD
Folic Acid—Dyspnoea—Cabazitaxel—prostate cancer	0.000356	0.00464	CcSEcCtD
Folic Acid—Dyspepsia—Cabazitaxel—prostate cancer	0.000351	0.00459	CcSEcCtD
Folic Acid—Feeling abnormal—Degarelix—prostate cancer	0.000349	0.00456	CcSEcCtD
Folic Acid—ABCC3—lymph node—prostate cancer	0.000349	0.00584	CbGeAlD
Folic Acid—Decreased appetite—Cabazitaxel—prostate cancer	0.000347	0.00453	CcSEcCtD
Folic Acid—Confusional state—Bicalutamide—prostate cancer	0.000345	0.00451	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.000345	0.0045	CcSEcCtD
Folic Acid—Rash—Estramustine—prostate cancer	0.000337	0.0044	CcSEcCtD
Folic Acid—Dermatitis—Estramustine—prostate cancer	0.000337	0.00439	CcSEcCtD
Folic Acid—Pruritus—Nilutamide—prostate cancer	0.000336	0.00438	CcSEcCtD
Folic Acid—Abdominal distension—Estradiol—prostate cancer	0.000334	0.00436	CcSEcCtD
Folic Acid—Pruritus—Flutamide—prostate cancer	0.000334	0.00436	CcSEcCtD
Folic Acid—Ill-defined disorder—Ethinyl Estradiol—prostate cancer	0.000329	0.00429	CcSEcCtD
Folic Acid—Feeling abnormal—Cabazitaxel—prostate cancer	0.000329	0.00429	CcSEcCtD
Folic Acid—ABCG2—bone marrow—prostate cancer	0.000328	0.00549	CbGeAlD
Folic Acid—Rash—Abiraterone—prostate cancer	0.000327	0.00427	CcSEcCtD
Folic Acid—Dermatitis—Abiraterone—prostate cancer	0.000327	0.00427	CcSEcCtD
Folic Acid—Bronchospasm—Estradiol—prostate cancer	0.000327	0.00426	CcSEcCtD
Folic Acid—Anorexia—Bicalutamide—prostate cancer	0.000326	0.00426	CcSEcCtD
Folic Acid—Rash—Estrone—prostate cancer	0.000322	0.0042	CcSEcCtD
Folic Acid—Dermatitis—Estrone—prostate cancer	0.000322	0.0042	CcSEcCtD
Folic Acid—Malaise—Ethinyl Estradiol—prostate cancer	0.00032	0.00417	CcSEcCtD
Folic Acid—Nausea—Estramustine—prostate cancer	0.000317	0.00414	CcSEcCtD
Folic Acid—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000315	0.00411	CcSEcCtD
Folic Acid—Dyspnoea—Bicalutamide—prostate cancer	0.000305	0.00398	CcSEcCtD
Folic Acid—Nausea—Estrone—prostate cancer	0.000303	0.00396	CcSEcCtD
Folic Acid—Dyspepsia—Bicalutamide—prostate cancer	0.000301	0.00393	CcSEcCtD
Folic Acid—Pruritus—Degarelix—prostate cancer	0.0003	0.00391	CcSEcCtD
Folic Acid—Rash—Nilutamide—prostate cancer	0.000299	0.0039	CcSEcCtD
Folic Acid—Dermatitis—Nilutamide—prostate cancer	0.000299	0.0039	CcSEcCtD
Folic Acid—Discomfort—Ethinyl Estradiol—prostate cancer	0.000298	0.00389	CcSEcCtD
Folic Acid—Rash—Flutamide—prostate cancer	0.000298	0.00389	CcSEcCtD
Folic Acid—Decreased appetite—Bicalutamide—prostate cancer	0.000298	0.00388	CcSEcCtD
Folic Acid—Dermatitis—Flutamide—prostate cancer	0.000297	0.00388	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000296	0.00386	CcSEcCtD
Folic Acid—Depression—Estradiol—prostate cancer	0.000295	0.00385	CcSEcCtD
Folic Acid—Tetrahydrofolic acid—MTHFR—prostate cancer	0.000292	0.0792	CrCbGaD
Folic Acid—Erythema—Goserelin—prostate cancer	0.000292	0.00381	CcSEcCtD
Folic Acid—Erythema—Conjugated Estrogens—prostate cancer	0.000289	0.00377	CcSEcCtD
Folic Acid—ABCC4—lymph node—prostate cancer	0.000288	0.00482	CbGeAlD
Folic Acid—Flatulence—Goserelin—prostate cancer	0.000288	0.00375	CcSEcCtD
Folic Acid—Flatulence—Conjugated Estrogens—prostate cancer	0.000285	0.00372	CcSEcCtD
Folic Acid—Dysgeusia—Conjugated Estrogens—prostate cancer	0.000283	0.00369	CcSEcCtD
Folic Acid—Feeling abnormal—Bicalutamide—prostate cancer	0.000282	0.00368	CcSEcCtD
Folic Acid—Nausea—Nilutamide—prostate cancer	0.000282	0.00368	CcSEcCtD
Folic Acid—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000281	0.00367	CcSEcCtD
Folic Acid—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000281	0.00366	CcSEcCtD
Folic Acid—ABCG2—testis—prostate cancer	0.00028	0.00469	CbGeAlD
Folic Acid—Nausea—Flutamide—prostate cancer	0.00028	0.00366	CcSEcCtD
Folic Acid—Ill-defined disorder—Goserelin—prostate cancer	0.000271	0.00353	CcSEcCtD
Folic Acid—Rash—Degarelix—prostate cancer	0.000267	0.00349	CcSEcCtD
Folic Acid—Dermatitis—Degarelix—prostate cancer	0.000267	0.00348	CcSEcCtD
Folic Acid—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000265	0.00345	CcSEcCtD
Folic Acid—Malaise—Goserelin—prostate cancer	0.000263	0.00343	CcSEcCtD
Folic Acid—Bronchospasm—Etoposide—prostate cancer	0.000253	0.0033	CcSEcCtD
Folic Acid—Convulsion—Goserelin—prostate cancer	0.000253	0.0033	CcSEcCtD
Folic Acid—Nausea—Degarelix—prostate cancer	0.000252	0.00328	CcSEcCtD
Folic Acid—Methotrexate—TYMS—prostate cancer	0.000251	0.0681	CrCbGaD
Folic Acid—Convulsion—Conjugated Estrogens—prostate cancer	0.00025	0.00327	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.00025	0.00326	CcSEcCtD
Folic Acid—Discomfort—Goserelin—prostate cancer	0.000245	0.0032	CcSEcCtD
Folic Acid—CYP2E1—testis—prostate cancer	0.000243	0.00406	CbGeAlD
Folic Acid—Pruritus—Bicalutamide—prostate cancer	0.000242	0.00316	CcSEcCtD
Folic Acid—Confusional state—Goserelin—prostate cancer	0.00024	0.00313	CcSEcCtD
Folic Acid—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000238	0.00311	CcSEcCtD
Folic Acid—Anaphylactic shock—Goserelin—prostate cancer	0.000238	0.00311	CcSEcCtD
Folic Acid—Nausea—Cabazitaxel—prostate cancer	0.000237	0.00309	CcSEcCtD
Folic Acid—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.000236	0.00308	CcSEcCtD
Folic Acid—Erythema—Estradiol—prostate cancer	0.000231	0.00302	CcSEcCtD
Folic Acid—Irritability—Capecitabine—prostate cancer	0.000229	0.00298	CcSEcCtD
Folic Acid—Flatulence—Estradiol—prostate cancer	0.000228	0.00298	CcSEcCtD
Folic Acid—Anorexia—Goserelin—prostate cancer	0.000227	0.00296	CcSEcCtD
Folic Acid—Dysgeusia—Estradiol—prostate cancer	0.000227	0.00296	CcSEcCtD
Folic Acid—Anorexia—Conjugated Estrogens—prostate cancer	0.000225	0.00293	CcSEcCtD
Folic Acid—Rash—Bicalutamide—prostate cancer	0.000216	0.00282	CcSEcCtD
Folic Acid—Dermatitis—Bicalutamide—prostate cancer	0.000216	0.00281	CcSEcCtD
Folic Acid—Erythema—Mitoxantrone—prostate cancer	0.000216	0.00281	CcSEcCtD
Folic Acid—Ill-defined disorder—Estradiol—prostate cancer	0.000215	0.0028	CcSEcCtD
Folic Acid—Agitation—Estradiol—prostate cancer	0.000213	0.00277	CcSEcCtD
Folic Acid—Dyspnoea—Goserelin—prostate cancer	0.000212	0.00277	CcSEcCtD
Folic Acid—Dysgeusia—Mitoxantrone—prostate cancer	0.000211	0.00276	CcSEcCtD
Folic Acid—Bronchospasm—Docetaxel—prostate cancer	0.00021	0.00275	CcSEcCtD
Folic Acid—Dyspnoea—Conjugated Estrogens—prostate cancer	0.00021	0.00275	CcSEcCtD
Folic Acid—Dyspepsia—Goserelin—prostate cancer	0.00021	0.00274	CcSEcCtD
Folic Acid—Malaise—Estradiol—prostate cancer	0.000209	0.00272	CcSEcCtD
Folic Acid—Abdominal distension—Capecitabine—prostate cancer	0.000208	0.00272	CcSEcCtD
Folic Acid—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000208	0.00271	CcSEcCtD
Folic Acid—Decreased appetite—Goserelin—prostate cancer	0.000207	0.0027	CcSEcCtD
Folic Acid—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000205	0.00268	CcSEcCtD
Folic Acid—Pruritus—Ethinyl Estradiol—prostate cancer	0.000205	0.00267	CcSEcCtD
Folic Acid—Irritability—Prednisone—prostate cancer	0.000204	0.00266	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000204	0.00266	CcSEcCtD
Folic Acid—Bronchospasm—Capecitabine—prostate cancer	0.000204	0.00266	CcSEcCtD
Folic Acid—Nausea—Bicalutamide—prostate cancer	0.000203	0.00265	CcSEcCtD
Folic Acid—ABCG2—lymph node—prostate cancer	0.000203	0.0034	CbGeAlD
Folic Acid—Ill-defined disorder—Mitoxantrone—prostate cancer	0.0002	0.00261	CcSEcCtD
Folic Acid—Methotrexate—MTHFR—prostate cancer	0.0002	0.0542	CrCbGaD
Folic Acid—Feeling abnormal—Goserelin—prostate cancer	0.000196	0.00256	CcSEcCtD
Folic Acid—Discomfort—Estradiol—prostate cancer	0.000195	0.00254	CcSEcCtD
Folic Acid—Malaise—Mitoxantrone—prostate cancer	0.000194	0.00254	CcSEcCtD
Folic Acid—Confusional state—Estradiol—prostate cancer	0.00019	0.00248	CcSEcCtD
Folic Acid—Anaphylactic shock—Estradiol—prostate cancer	0.000189	0.00246	CcSEcCtD
Folic Acid—Convulsion—Mitoxantrone—prostate cancer	0.000187	0.00244	CcSEcCtD
Folic Acid—Abdominal distension—Prednisone—prostate cancer	0.000186	0.00242	CcSEcCtD
Folic Acid—Depression—Capecitabine—prostate cancer	0.000184	0.0024	CcSEcCtD
Folic Acid—Rash—Ethinyl Estradiol—prostate cancer	0.000182	0.00238	CcSEcCtD
Folic Acid—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000182	0.00238	CcSEcCtD
Folic Acid—Discomfort—Mitoxantrone—prostate cancer	0.000181	0.00237	CcSEcCtD
Folic Acid—Confusional state—Mitoxantrone—prostate cancer	0.000177	0.00232	CcSEcCtD
Folic Acid—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000176	0.0023	CcSEcCtD
Folic Acid—Dysgeusia—Etoposide—prostate cancer	0.000176	0.00229	CcSEcCtD
Folic Acid—Nausea—Ethinyl Estradiol—prostate cancer	0.000172	0.00224	CcSEcCtD
Folic Acid—Pruritus—Goserelin—prostate cancer	0.000169	0.0022	CcSEcCtD
Folic Acid—Dyspnoea—Estradiol—prostate cancer	0.000168	0.0022	CcSEcCtD
Folic Acid—Anorexia—Mitoxantrone—prostate cancer	0.000168	0.00219	CcSEcCtD
Folic Acid—Pruritus—Conjugated Estrogens—prostate cancer	0.000167	0.00218	CcSEcCtD
Folic Acid—Ill-defined disorder—Etoposide—prostate cancer	0.000166	0.00217	CcSEcCtD
Folic Acid—Dyspepsia—Estradiol—prostate cancer	0.000166	0.00217	CcSEcCtD
Folic Acid—Decreased appetite—Estradiol—prostate cancer	0.000164	0.00214	CcSEcCtD
Folic Acid—Depression—Prednisone—prostate cancer	0.000164	0.00214	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Estradiol—prostate cancer	0.000163	0.00213	CcSEcCtD
Folic Acid—Malaise—Etoposide—prostate cancer	0.000162	0.00211	CcSEcCtD
Folic Acid—Dyspnoea—Mitoxantrone—prostate cancer	0.000157	0.00205	CcSEcCtD
Folic Acid—Feeling abnormal—Estradiol—prostate cancer	0.000156	0.00203	CcSEcCtD
Folic Acid—Convulsion—Etoposide—prostate cancer	0.000155	0.00203	CcSEcCtD
Folic Acid—Dyspepsia—Mitoxantrone—prostate cancer	0.000155	0.00202	CcSEcCtD
Folic Acid—Decreased appetite—Mitoxantrone—prostate cancer	0.000153	0.002	CcSEcCtD
Folic Acid—Discomfort—Etoposide—prostate cancer	0.000151	0.00197	CcSEcCtD
Folic Acid—Rash—Goserelin—prostate cancer	0.00015	0.00196	CcSEcCtD
Folic Acid—Dermatitis—Goserelin—prostate cancer	0.00015	0.00196	CcSEcCtD
Folic Acid—Erythema—Docetaxel—prostate cancer	0.000149	0.00194	CcSEcCtD
Folic Acid—Rash—Conjugated Estrogens—prostate cancer	0.000149	0.00194	CcSEcCtD
Folic Acid—Dermatitis—Conjugated Estrogens—prostate cancer	0.000149	0.00194	CcSEcCtD
Folic Acid—Confusional state—Etoposide—prostate cancer	0.000148	0.00193	CcSEcCtD
Folic Acid—Anaphylactic shock—Etoposide—prostate cancer	0.000146	0.00191	CcSEcCtD
Folic Acid—Dysgeusia—Docetaxel—prostate cancer	0.000146	0.0019	CcSEcCtD
Folic Acid—Abdominal distension—Epirubicin—prostate cancer	0.000145	0.0019	CcSEcCtD
Folic Acid—Feeling abnormal—Mitoxantrone—prostate cancer	0.000145	0.00189	CcSEcCtD
Folic Acid—Erythema—Capecitabine—prostate cancer	0.000144	0.00188	CcSEcCtD
Folic Acid—Flatulence—Capecitabine—prostate cancer	0.000142	0.00186	CcSEcCtD
Folic Acid—Nausea—Goserelin—prostate cancer	0.000141	0.00185	CcSEcCtD
Folic Acid—Dysgeusia—Capecitabine—prostate cancer	0.000141	0.00184	CcSEcCtD
Folic Acid—Nausea—Conjugated Estrogens—prostate cancer	0.00014	0.00183	CcSEcCtD
Folic Acid—Anorexia—Etoposide—prostate cancer	0.000139	0.00182	CcSEcCtD
Folic Acid—Abdominal distension—Doxorubicin—prostate cancer	0.000134	0.00175	CcSEcCtD
Folic Acid—Ill-defined disorder—Capecitabine—prostate cancer	0.000134	0.00175	CcSEcCtD
Folic Acid—Pruritus—Estradiol—prostate cancer	0.000134	0.00174	CcSEcCtD
Folic Acid—Dyspnoea—Etoposide—prostate cancer	0.00013	0.0017	CcSEcCtD
Folic Acid—Malaise—Capecitabine—prostate cancer	0.00013	0.0017	CcSEcCtD
Folic Acid—Convulsion—Docetaxel—prostate cancer	0.000129	0.00169	CcSEcCtD
Folic Acid—Erythema—Prednisone—prostate cancer	0.000129	0.00168	CcSEcCtD
Folic Acid—Decreased appetite—Etoposide—prostate cancer	0.000127	0.00166	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Etoposide—prostate cancer	0.000126	0.00165	CcSEcCtD
Folic Acid—Confusional state—Docetaxel—prostate cancer	0.000123	0.0016	CcSEcCtD
Folic Acid—Anaphylactic shock—Docetaxel—prostate cancer	0.000122	0.00159	CcSEcCtD
Folic Acid—Discomfort—Capecitabine—prostate cancer	0.000121	0.00158	CcSEcCtD
Folic Acid—Feeling abnormal—Etoposide—prostate cancer	0.000121	0.00157	CcSEcCtD
Folic Acid—Ill-defined disorder—Prednisone—prostate cancer	0.000119	0.00156	CcSEcCtD
Folic Acid—Rash—Estradiol—prostate cancer	0.000119	0.00155	CcSEcCtD
Folic Acid—Dermatitis—Estradiol—prostate cancer	0.000119	0.00155	CcSEcCtD
Folic Acid—Confusional state—Capecitabine—prostate cancer	0.000119	0.00155	CcSEcCtD
Folic Acid—Agitation—Prednisone—prostate cancer	0.000118	0.00154	CcSEcCtD
Folic Acid—Anorexia—Docetaxel—prostate cancer	0.000116	0.00151	CcSEcCtD
Folic Acid—Malaise—Prednisone—prostate cancer	0.000116	0.00151	CcSEcCtD
Folic Acid—Anorexia—Capecitabine—prostate cancer	0.000112	0.00146	CcSEcCtD
Folic Acid—Nausea—Estradiol—prostate cancer	0.000112	0.00146	CcSEcCtD
Folic Acid—Convulsion—Prednisone—prostate cancer	0.000111	0.00145	CcSEcCtD
Folic Acid—Rash—Mitoxantrone—prostate cancer	0.000111	0.00145	CcSEcCtD
Folic Acid—Dermatitis—Mitoxantrone—prostate cancer	0.000111	0.00145	CcSEcCtD
Folic Acid—Dyspnoea—Docetaxel—prostate cancer	0.000108	0.00142	CcSEcCtD
Folic Acid—Discomfort—Prednisone—prostate cancer	0.000108	0.00141	CcSEcCtD
Folic Acid—Dyspepsia—Docetaxel—prostate cancer	0.000107	0.0014	CcSEcCtD
Folic Acid—Decreased appetite—Docetaxel—prostate cancer	0.000106	0.00138	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000105	0.00137	CcSEcCtD
Folic Acid—Dyspnoea—Capecitabine—prostate cancer	0.000105	0.00137	CcSEcCtD
Folic Acid—Anaphylactic shock—Prednisone—prostate cancer	0.000105	0.00137	CcSEcCtD
Folic Acid—Nausea—Mitoxantrone—prostate cancer	0.000104	0.00136	CcSEcCtD
Folic Acid—Dyspepsia—Capecitabine—prostate cancer	0.000104	0.00135	CcSEcCtD
Folic Acid—Pruritus—Etoposide—prostate cancer	0.000104	0.00135	CcSEcCtD
Folic Acid—Decreased appetite—Capecitabine—prostate cancer	0.000102	0.00134	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000102	0.00133	CcSEcCtD
Folic Acid—Erythema—Epirubicin—prostate cancer	0.000101	0.00131	CcSEcCtD
Folic Acid—Feeling abnormal—Docetaxel—prostate cancer	0.0001	0.00131	CcSEcCtD
Folic Acid—Anorexia—Prednisone—prostate cancer	0.0001	0.0013	CcSEcCtD
Folic Acid—Flatulence—Epirubicin—prostate cancer	9.9e-05	0.00129	CcSEcCtD
Folic Acid—Dysgeusia—Epirubicin—prostate cancer	9.84e-05	0.00128	CcSEcCtD
Folic Acid—Feeling abnormal—Capecitabine—prostate cancer	9.7e-05	0.00127	CcSEcCtD
Folic Acid—Ill-defined disorder—Epirubicin—prostate cancer	9.33e-05	0.00122	CcSEcCtD
Folic Acid—Erythema—Doxorubicin—prostate cancer	9.3e-05	0.00121	CcSEcCtD
Folic Acid—Agitation—Epirubicin—prostate cancer	9.24e-05	0.00121	CcSEcCtD
Folic Acid—Dyspepsia—Prednisone—prostate cancer	9.23e-05	0.0012	CcSEcCtD
Folic Acid—Rash—Etoposide—prostate cancer	9.23e-05	0.0012	CcSEcCtD
Folic Acid—Dermatitis—Etoposide—prostate cancer	9.22e-05	0.0012	CcSEcCtD
Folic Acid—Flatulence—Doxorubicin—prostate cancer	9.16e-05	0.0012	CcSEcCtD
Folic Acid—Decreased appetite—Prednisone—prostate cancer	9.12e-05	0.00119	CcSEcCtD
Folic Acid—Dysgeusia—Doxorubicin—prostate cancer	9.11e-05	0.00119	CcSEcCtD
Folic Acid—Malaise—Epirubicin—prostate cancer	9.06e-05	0.00118	CcSEcCtD
Folic Acid—Convulsion—Epirubicin—prostate cancer	8.71e-05	0.00114	CcSEcCtD
Folic Acid—Nausea—Etoposide—prostate cancer	8.69e-05	0.00113	CcSEcCtD
Folic Acid—Feeling abnormal—Prednisone—prostate cancer	8.64e-05	0.00113	CcSEcCtD
Folic Acid—Ill-defined disorder—Doxorubicin—prostate cancer	8.63e-05	0.00113	CcSEcCtD
Folic Acid—Pruritus—Docetaxel—prostate cancer	8.6e-05	0.00112	CcSEcCtD
Folic Acid—Agitation—Doxorubicin—prostate cancer	8.55e-05	0.00112	CcSEcCtD
Folic Acid—Discomfort—Epirubicin—prostate cancer	8.45e-05	0.0011	CcSEcCtD
Folic Acid—Malaise—Doxorubicin—prostate cancer	8.39e-05	0.00109	CcSEcCtD
Folic Acid—Pruritus—Capecitabine—prostate cancer	8.33e-05	0.00109	CcSEcCtD
Folic Acid—Confusional state—Epirubicin—prostate cancer	8.27e-05	0.00108	CcSEcCtD
Folic Acid—Anaphylactic shock—Epirubicin—prostate cancer	8.2e-05	0.00107	CcSEcCtD
Folic Acid—Convulsion—Doxorubicin—prostate cancer	8.06e-05	0.00105	CcSEcCtD
Folic Acid—Discomfort—Doxorubicin—prostate cancer	7.82e-05	0.00102	CcSEcCtD
Folic Acid—Anorexia—Epirubicin—prostate cancer	7.82e-05	0.00102	CcSEcCtD
Folic Acid—Rash—Docetaxel—prostate cancer	7.67e-05	0.001	CcSEcCtD
Folic Acid—Dermatitis—Docetaxel—prostate cancer	7.66e-05	0.001	CcSEcCtD
Folic Acid—Confusional state—Doxorubicin—prostate cancer	7.65e-05	0.000999	CcSEcCtD
Folic Acid—Anaphylactic shock—Doxorubicin—prostate cancer	7.59e-05	0.000991	CcSEcCtD
Folic Acid—Rash—Capecitabine—prostate cancer	7.42e-05	0.000969	CcSEcCtD
Folic Acid—Pruritus—Prednisone—prostate cancer	7.42e-05	0.000968	CcSEcCtD
Folic Acid—Dermatitis—Capecitabine—prostate cancer	7.42e-05	0.000968	CcSEcCtD
Folic Acid—Dyspnoea—Epirubicin—prostate cancer	7.31e-05	0.000954	CcSEcCtD
Folic Acid—Anorexia—Doxorubicin—prostate cancer	7.23e-05	0.000944	CcSEcCtD
Folic Acid—Nausea—Docetaxel—prostate cancer	7.22e-05	0.000943	CcSEcCtD
Folic Acid—Dyspepsia—Epirubicin—prostate cancer	7.22e-05	0.000942	CcSEcCtD
Folic Acid—Decreased appetite—Epirubicin—prostate cancer	7.13e-05	0.000931	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Epirubicin—prostate cancer	7.08e-05	0.000924	CcSEcCtD
Folic Acid—Nausea—Capecitabine—prostate cancer	6.99e-05	0.000913	CcSEcCtD
Folic Acid—Dyspnoea—Doxorubicin—prostate cancer	6.77e-05	0.000883	CcSEcCtD
Folic Acid—Feeling abnormal—Epirubicin—prostate cancer	6.76e-05	0.000882	CcSEcCtD
Folic Acid—Dyspepsia—Doxorubicin—prostate cancer	6.68e-05	0.000872	CcSEcCtD
Folic Acid—Rash—Prednisone—prostate cancer	6.61e-05	0.000863	CcSEcCtD
Folic Acid—Dermatitis—Prednisone—prostate cancer	6.61e-05	0.000862	CcSEcCtD
Folic Acid—Decreased appetite—Doxorubicin—prostate cancer	6.6e-05	0.000861	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Doxorubicin—prostate cancer	6.55e-05	0.000855	CcSEcCtD
Folic Acid—Feeling abnormal—Doxorubicin—prostate cancer	6.25e-05	0.000816	CcSEcCtD
Folic Acid—Nausea—Prednisone—prostate cancer	6.23e-05	0.000813	CcSEcCtD
Folic Acid—Pruritus—Epirubicin—prostate cancer	5.8e-05	0.000757	CcSEcCtD
Folic Acid—Pruritus—Doxorubicin—prostate cancer	5.37e-05	0.000701	CcSEcCtD
Folic Acid—Rash—Epirubicin—prostate cancer	5.17e-05	0.000675	CcSEcCtD
Folic Acid—Dermatitis—Epirubicin—prostate cancer	5.17e-05	0.000674	CcSEcCtD
Folic Acid—Nausea—Epirubicin—prostate cancer	4.87e-05	0.000636	CcSEcCtD
Folic Acid—Rash—Doxorubicin—prostate cancer	4.79e-05	0.000625	CcSEcCtD
Folic Acid—Dermatitis—Doxorubicin—prostate cancer	4.78e-05	0.000624	CcSEcCtD
Folic Acid—Nausea—Doxorubicin—prostate cancer	4.51e-05	0.000588	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—PIK3CB—prostate cancer	7.48e-06	6.9e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.47e-06	6.89e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—ERCC2—prostate cancer	7.46e-06	6.88e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTA2—prostate cancer	7.45e-06	6.88e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TNFRSF21—prostate cancer	7.45e-06	6.87e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PTGS2—prostate cancer	7.42e-06	6.84e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EP300—prostate cancer	7.36e-06	6.79e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—SULT1A1—prostate cancer	7.36e-06	6.79e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ABCG5—prostate cancer	7.36e-06	6.79e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—NOS3—prostate cancer	7.28e-06	6.72e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—BAD—prostate cancer	7.27e-06	6.7e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—MTAP—prostate cancer	7.25e-06	6.69e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP7B1—prostate cancer	7.25e-06	6.69e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NCOA2—prostate cancer	7.21e-06	6.66e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTA1—prostate cancer	7.19e-06	6.63e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—SRC—prostate cancer	7.16e-06	6.61e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTO1—prostate cancer	7.11e-06	6.56e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NAT2—prostate cancer	7.11e-06	6.56e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—HSD3B2—prostate cancer	7.11e-06	6.56e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—JAK2—prostate cancer	7.08e-06	6.53e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SULT1E1—prostate cancer	7.06e-06	6.52e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SRD5A1—prostate cancer	7.06e-06	6.52e-05	CbGpPWpGaD
Folic Acid—ABCC4—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.04e-06	6.49e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—APC—prostate cancer	7.04e-06	6.49e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EGF—prostate cancer	6.96e-06	6.42e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—IRS1—prostate cancer	6.96e-06	6.42e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—STAT3—prostate cancer	6.91e-06	6.37e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—SLC5A5—prostate cancer	6.88e-06	6.35e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PPARA—prostate cancer	6.88e-06	6.35e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—LRP2—prostate cancer	6.82e-06	6.29e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP2C18—prostate cancer	6.82e-06	6.29e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PLCB2—prostate cancer	6.82e-06	6.29e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—GSK3B—prostate cancer	6.75e-06	6.23e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ACSL4—prostate cancer	6.74e-06	6.22e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—HSD17B3—prostate cancer	6.74e-06	6.22e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP2E1—prostate cancer	6.72e-06	6.2e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—PIK3CB—prostate cancer	6.72e-06	6.2e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—P4HB—prostate cancer	6.69e-06	6.17e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—INS—prostate cancer	6.66e-06	6.15e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NQO1—prostate cancer	6.65e-06	6.13e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—TH—prostate cancer	6.55e-06	6.04e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CREBBP—prostate cancer	6.52e-06	6.02e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.51e-06	6e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—SLC22A1—prostate cancer	6.5e-06	6e-05	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—PPARA—prostate cancer	6.5e-06	6e-05	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—AKT1—prostate cancer	6.49e-06	5.99e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP3A4—prostate cancer	6.48e-06	5.98e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CAV1—prostate cancer	6.47e-06	5.97e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PTEN—prostate cancer	6.47e-06	5.97e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PHGDH—prostate cancer	6.46e-06	5.96e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—UMPS—prostate cancer	6.46e-06	5.96e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ARG2—prostate cancer	6.46e-06	5.96e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.45e-06	5.95e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—MYC—prostate cancer	6.42e-06	5.92e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—TGFB1—prostate cancer	6.4e-06	5.91e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP1B1—prostate cancer	6.37e-06	5.88e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—SULT2A1—prostate cancer	6.34e-06	5.85e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—LDHB—prostate cancer	6.33e-06	5.84e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EGFR—prostate cancer	6.28e-06	5.79e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—MED12—prostate cancer	6.24e-06	5.75e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MAP2K1—prostate cancer	6.23e-06	5.75e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP3A5—prostate cancer	6.22e-06	5.74e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GNG5—prostate cancer	6.19e-06	5.71e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PIK3CD—prostate cancer	6.19e-06	5.71e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—IL2—prostate cancer	6.17e-06	5.69e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GGT1—prostate cancer	6.17e-06	5.69e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—EP300—prostate cancer	6.17e-06	5.69e-05	CbGpPWpGaD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.13e-06	5.65e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—SERPINE1—prostate cancer	6.12e-06	5.64e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NCOA1—prostate cancer	6.08e-06	5.61e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PDHA1—prostate cancer	6e-06	5.54e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—UCP3—prostate cancer	6e-06	5.54e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTA3—prostate cancer	6e-06	5.54e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TCN2—prostate cancer	6e-06	5.54e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP19A1—prostate cancer	5.99e-06	5.53e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NCOA3—prostate cancer	5.96e-06	5.5e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—KRAS—prostate cancer	5.93e-06	5.47e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—FGF2—prostate cancer	5.92e-06	5.46e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PIK3CG—prostate cancer	5.89e-06	5.44e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—NOS3—prostate cancer	5.84e-06	5.39e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—RXRA—prostate cancer	5.78e-06	5.33e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SLC22A3—prostate cancer	5.73e-06	5.28e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—HSD3B1—prostate cancer	5.73e-06	5.28e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—HPGDS—prostate cancer	5.69e-06	5.24e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—JAK2—prostate cancer	5.68e-06	5.24e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP2C19—prostate cancer	5.65e-06	5.21e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.62e-06	5.19e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—INS—prostate cancer	5.58e-06	5.15e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—COMT—prostate cancer	5.57e-06	5.14e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTP1—prostate cancer	5.54e-06	5.11e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MDM2—prostate cancer	5.54e-06	5.11e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—EP300—prostate cancer	5.54e-06	5.11e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ACHE—prostate cancer	5.51e-06	5.09e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTT1—prostate cancer	5.51e-06	5.09e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTA4—prostate cancer	5.49e-06	5.07e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TBXAS1—prostate cancer	5.49e-06	5.07e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CREBBP—prostate cancer	5.46e-06	5.04e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—ERBB2—prostate cancer	5.46e-06	5.04e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—ITPR1—prostate cancer	5.45e-06	5.03e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP2A6—prostate cancer	5.45e-06	5.03e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—PIK3CA—prostate cancer	5.45e-06	5.03e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PIK3CB—prostate cancer	5.39e-06	4.97e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—SRC—prostate cancer	5.39e-06	4.97e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.36e-06	4.95e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTA2—prostate cancer	5.35e-06	4.94e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PTGS2—prostate cancer	5.34e-06	4.93e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—AKR1C3—prostate cancer	5.3e-06	4.89e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SULT1A1—prostate cancer	5.29e-06	4.88e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ABCG5—prostate cancer	5.29e-06	4.88e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PRKACB—prostate cancer	5.27e-06	4.87e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—VEGFA—prostate cancer	5.25e-06	4.84e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP17A1—prostate cancer	5.22e-06	4.82e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PIK3CD—prostate cancer	5.18e-06	4.78e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTA1—prostate cancer	5.16e-06	4.76e-05	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.16e-06	4.76e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—TYMS—prostate cancer	5.15e-06	4.75e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NAT2—prostate cancer	5.11e-06	4.71e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—HSD3B2—prostate cancer	5.11e-06	4.71e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTO1—prostate cancer	5.11e-06	4.71e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—GSTM1—prostate cancer	5.09e-06	4.7e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CDKN1B—prostate cancer	5.06e-06	4.67e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—LPL—prostate cancer	5e-06	4.61e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NCOA2—prostate cancer	4.97e-06	4.59e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP2C18—prostate cancer	4.9e-06	4.52e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—LRP2—prostate cancer	4.9e-06	4.52e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PLCB2—prostate cancer	4.9e-06	4.52e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—NOS3—prostate cancer	4.89e-06	4.51e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CYP1A1—prostate cancer	4.83e-06	4.46e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—IL6—prostate cancer	4.82e-06	4.45e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TGFB1—prostate cancer	4.81e-06	4.44e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—P4HB—prostate cancer	4.8e-06	4.43e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—ERCC2—prostate cancer	4.79e-06	4.42e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CTNNB1—prostate cancer	4.78e-06	4.41e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—SLC5A5—prostate cancer	4.74e-06	4.38e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CDKN1A—prostate cancer	4.67e-06	4.31e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SLC22A1—prostate cancer	4.67e-06	4.31e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PTEN—prostate cancer	4.66e-06	4.3e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP2E1—prostate cancer	4.63e-06	4.28e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NQO1—prostate cancer	4.58e-06	4.23e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PIK3CA—prostate cancer	4.56e-06	4.21e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SULT2A1—prostate cancer	4.55e-06	4.2e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—TH—prostate cancer	4.52e-06	4.17e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PIK3CB—prostate cancer	4.52e-06	4.17e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—MTHFR—prostate cancer	4.5e-06	4.15e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—MED12—prostate cancer	4.48e-06	4.13e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PTGS2—prostate cancer	4.47e-06	4.13e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP3A4—prostate cancer	4.47e-06	4.12e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—KRAS—prostate cancer	4.46e-06	4.11e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—AKT1—prostate cancer	4.45e-06	4.11e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EP300—prostate cancer	4.44e-06	4.1e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GNG5—prostate cancer	4.44e-06	4.1e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PPARA—prostate cancer	4.42e-06	4.07e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP1B1—prostate cancer	4.39e-06	4.05e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—SRC—prostate cancer	4.32e-06	3.99e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NCOA3—prostate cancer	4.28e-06	3.95e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GGT1—prostate cancer	4.26e-06	3.93e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NCOA1—prostate cancer	4.19e-06	3.87e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—STAT3—prostate cancer	4.17e-06	3.84e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CAV1—prostate cancer	4.15e-06	3.83e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP19A1—prostate cancer	4.13e-06	3.81e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—PIK3CA—prostate cancer	4.1e-06	3.78e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—HPGDS—prostate cancer	4.08e-06	3.77e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP2C19—prostate cancer	4.06e-06	3.74e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—RXRA—prostate cancer	3.99e-06	3.68e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.97e-06	3.66e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TP53—prostate cancer	3.96e-06	3.66e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTT1—prostate cancer	3.96e-06	3.65e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ACHE—prostate cancer	3.96e-06	3.65e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP2A6—prostate cancer	3.91e-06	3.61e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PTEN—prostate cancer	3.9e-06	3.6e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MYC—prostate cancer	3.87e-06	3.57e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—TGFB1—prostate cancer	3.86e-06	3.56e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—COMT—prostate cancer	3.84e-06	3.54e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTP1—prostate cancer	3.82e-06	3.53e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—AKR1C3—prostate cancer	3.81e-06	3.51e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EGFR—prostate cancer	3.79e-06	3.49e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PRKACB—prostate cancer	3.79e-06	3.49e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PIK3CG—prostate cancer	3.78e-06	3.49e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ITPR1—prostate cancer	3.76e-06	3.47e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP17A1—prostate cancer	3.75e-06	3.46e-05	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—AKT1—prostate cancer	3.73e-06	3.44e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—EP300—prostate cancer	3.72e-06	3.43e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—INS—prostate cancer	3.58e-06	3.3e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—KRAS—prostate cancer	3.58e-06	3.3e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NCOA2—prostate cancer	3.57e-06	3.29e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—TYMS—prostate cancer	3.55e-06	3.28e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—GSTM1—prostate cancer	3.51e-06	3.24e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CREBBP—prostate cancer	3.51e-06	3.24e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—LPL—prostate cancer	3.45e-06	3.18e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—SLC5A5—prostate cancer	3.41e-06	3.14e-05	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—AKT1—prostate cancer	3.35e-06	3.09e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CYP1A1—prostate cancer	3.33e-06	3.07e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PIK3CD—prostate cancer	3.33e-06	3.07e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ERCC2—prostate cancer	3.3e-06	3.05e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NQO1—prostate cancer	3.29e-06	3.04e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PIK3CA—prostate cancer	3.29e-06	3.03e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TH—prostate cancer	3.24e-06	2.99e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP3A4—prostate cancer	3.21e-06	2.96e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP1B1—prostate cancer	3.15e-06	2.91e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—NOS3—prostate cancer	3.14e-06	2.9e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—MTHFR—prostate cancer	3.1e-06	2.86e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GGT1—prostate cancer	3.05e-06	2.82e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PPARA—prostate cancer	3.05e-06	2.81e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NCOA1—prostate cancer	3.01e-06	2.78e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP19A1—prostate cancer	2.97e-06	2.74e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—IL6—prostate cancer	2.91e-06	2.69e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PIK3CB—prostate cancer	2.9e-06	2.67e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PTGS2—prostate cancer	2.87e-06	2.65e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CAV1—prostate cancer	2.86e-06	2.64e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—RXRA—prostate cancer	2.86e-06	2.64e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—COMT—prostate cancer	2.76e-06	2.54e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PIK3CA—prostate cancer	2.75e-06	2.54e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTP1—prostate cancer	2.74e-06	2.53e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ITPR1—prostate cancer	2.7e-06	2.49e-05	CbGpPWpGaD
Folic Acid—MTHFR—Disease—AKT1—prostate cancer	2.69e-06	2.48e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PIK3CG—prostate cancer	2.61e-06	2.41e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TYMS—prostate cancer	2.55e-06	2.35e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—GSTM1—prostate cancer	2.52e-06	2.33e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PTEN—prostate cancer	2.5e-06	2.31e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—LPL—prostate cancer	2.48e-06	2.28e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—INS—prostate cancer	2.47e-06	2.28e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CREBBP—prostate cancer	2.42e-06	2.23e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CYP1A1—prostate cancer	2.39e-06	2.21e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—EP300—prostate cancer	2.39e-06	2.2e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ERCC2—prostate cancer	2.37e-06	2.19e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PIK3CD—prostate cancer	2.29e-06	2.12e-05	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—AKT1—prostate cancer	2.25e-06	2.07e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—MTHFR—prostate cancer	2.23e-06	2.06e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PPARA—prostate cancer	2.19e-06	2.02e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—NOS3—prostate cancer	2.16e-06	2e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CAV1—prostate cancer	2.06e-06	1.9e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PIK3CB—prostate cancer	2e-06	1.84e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PTGS2—prostate cancer	1.98e-06	1.83e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.87e-06	1.73e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—INS—prostate cancer	1.77e-06	1.64e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PIK3CA—prostate cancer	1.77e-06	1.63e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CREBBP—prostate cancer	1.74e-06	1.6e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PTEN—prostate cancer	1.73e-06	1.59e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—EP300—prostate cancer	1.65e-06	1.52e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.65e-06	1.52e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—NOS3—prostate cancer	1.55e-06	1.43e-05	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—AKT1—prostate cancer	1.44e-06	1.33e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.43e-06	1.32e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PTGS2—prostate cancer	1.42e-06	1.31e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PTEN—prostate cancer	1.24e-06	1.14e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PIK3CA—prostate cancer	1.22e-06	1.12e-05	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—EP300—prostate cancer	1.18e-06	1.09e-05	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—AKT1—prostate cancer	9.95e-07	9.18e-06	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PIK3CA—prostate cancer	8.75e-07	8.07e-06	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—AKT1—prostate cancer	7.15e-07	6.59e-06	CbGpPWpGaD
